Polish biotechnology company IMAGENE.ME has raised €1.4 million (PLN 6 million) in a fresh investment round from ABAN.VC and NCBR Investment Fund. The capital injection will enable its global expansion and further development of technologies supporting health issues prevention and longevity. The startup has shared the news on its Linkedin page.
About IMAGENE.ME
-
IMAGENE.ME is a Białystok-based biotechnology startup founded by Mirosław Kwaśniewski back in 2018. Now, the company is garnering international prominence for its innovative personal genomics solutions.
-
Its pipeline product, IMAGENE.ME LIFE application provides personalised DNA analysis, health suggestions, and access to doctors and medical services as part of its integrated health ecosystem.
-
The company’s strategy incorporates the advancement of artificial intelligence technology to improve diagnostics and disease prevention.
“Our mission is to increase the availability of genomic testing so that everyone can consciously take care of their health,” says Dr. Hab. Mirosław Kwaśniewski, Vice President of IMAGENE.ME.
Investment details
ABAN.VC and NCBR Investment Fund's investment will allow the company to expand its services internationally.
-
Krakow-based ABAN.VC is an investment fund with a focus on investing in innovative early-stage companies, bringing together more than 40 investors.
-
NCBR Investment Fund is a VC instrument of the National Centre for Research and Development, an executive agency of the Minister of Science and Higher Education, focused on innovative (R&D) small and medium-size enterprises (SMEs) in growth & expansion stage.
Additionally, it will support new investments and partnerships, such as the LONGEVITY+ initiative, which will also help the company realise its goal of becoming a European leader.
